HDAC1 Inhibitor Screening Assay Kit

Cayman’s HDAC1 Inhibitor Screening Assay Kit provides a fast, fluorescence-based method for screening HDAC1 inhibitors. The procedure consists of two easy steps, both performed in the same microplate. In the first step, an acetylated lysine substrate is incubated with HDAC1. Deacetylation sensitizes the substrate such that treatment with the HDAC developer in the second step releases a fluorescent product. Trichostatin A is included as a control inhibitor. The fluorophore can be easily analyzed using a fluorescence plate reader with an excitation wavelength of 340-360 nm and an emission wavelength of 440-465 nm.

Needed but not supplied: Please download the kit booklet to verify if UltraPure Water (Milli-Q or equivalent) or any other components are needed for this assay.

WARNING This product is not for human or veterinary use.

Granit, A., Tetro, N., Shmuel, M., et al. Lacosamide at therapeutic concentrations induces histone hyperacetylation in vitro. Epilepsia Open 3(4), 535-539 (2018).